The American Psychiatric Association (APA) has updated its Privacy Policy and Terms of Use, including with new information specifically addressed to individuals in the European Economic Area. As described in the Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences.

Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.

×
CorrectionsFull Access

Corrections

Published Online:

Correction

An error during production caused the article by Hisato Matsunaga, M.D., Ph.D., and colleagues (“Symptom Structure in Japanese Patients With Obsessive-Compulsive Disorder,” published online November 15, 2007; doi: 10.1176/appi.ajp.2007.07020340) to be posted with some disclosure information missing:

Dr. Stein has received research grants and/or consultancy honoraria from AstraZeneca, Eli Lilly, GlaxoSmithKline, Johnson and Johnson, Lundbeck, Orion, Pfizer, Pharmacia, Roche, Servier, Solvay, Sumitomo, Tikvah, and Wyeth. All other authors report no competing interests.